H35.32
Exudative age-related macular degeneration
Clinical Classification Guidelines
Inclusion Terms
- Wet age-related macular degeneration
7th Character Definition
One of the following 7th characters is to be assigned to codes in subcategory H35.32 to designate the stage of the disease:
Medical Intelligence & Overview
Exudative age-related macular degeneration, also known as wet age-related macular degeneration, is a progressive eye disease that can lead to severe vision loss. It primarily affects the macula, the part of the retina responsible for central vision, making activities like reading and recognizing faces difficult. This condition is characterized by abnormal blood vessel growth beneath the retina, which can leak fluid or blood, damaging the macula. Recognizing the symptoms early and seeking medical attention can help manage the disease and preserve vision as much as possible.
Causes & Symptoms
Clinical Causes: Abnormal growth of new blood vessels beneath the retina Age-related changes in the eye's tissue Genetic factors that influence blood vessel growth High blood pressure and cardiovascular disease Smoking and exposure to environmental toxins
Key Symptoms: Sudden or gradual loss of central vision Visual distortions, such as straight lines appearing bent or crooked Dark or empty areas in the central visual field Difficulty recognizing faces, reading, or performing detail-oriented tasks Changes in color perception
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including visual acuity tests and imaging techniques. Diagnostic procedures may include:
Treatment Protocols: While exudative age-related macular degeneration cannot be cured, several treatments can slow progression and improve visual outcomes. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is H35.32 a billable ICD-10 code?
Yes, H35.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.32?
Clinical documentation must specify the nature of Exudative age-related macular degeneration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference